CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de CARLOS](/img/nophoto.png)
![Foto de Hospital Universitario de la Princesa](/img/noimage_org.png)
Hospital Universitario de la Princesa
Madrid, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario de la Princesa (50)
2024
-
Upper and/or Lower Respiratory Tract Infection Caused by Human Metapneumovirus After Allogeneic Hematopoietic Stem Cell Transplantation
Journal of Infectious Diseases, Vol. 229, Núm. 1, pp. 83-94
2023
2021
-
Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group
Transplant Infectious Disease, Vol. 23, Núm. 4
-
Clinical outcomes of allogeneic hematopoietic stem cell transplant recipients developing Cytomegalovirus DNAemia prior to engraftment
Bone Marrow Transplantation, Vol. 56, Núm. 6, pp. 1281-1290
-
Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group
American Journal of Transplantation, Vol. 21, Núm. 1, pp. 258-271
-
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study
Bone Marrow Transplantation, Vol. 56, Núm. 5, pp. 1171-1179
2020
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Network for Research in Infectious Diseases (REIPI) and the Spanish Society of Haematology and Haemotherapy (SEHH) on the management of febrile neutropenia in patients with hematological malignancies
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 174-181
-
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Experimental Hematology and Oncology, Vol. 9, Núm. 1
-
Use of micafungin as antifungal prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation (Allo-HSCT) in Spain (GETH-MIC)
Revista Espanola de Quimioterapia, Vol. 33, Núm. 2, pp. 110-115
2019
2018
-
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphisms
Blood Advances, Vol. 2, Núm. 14, pp. 1719-1737
-
PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation
Annals of Hematology, Vol. 97, Núm. 11, pp. 2217-2224
2017
-
IL28B genetic variation and cytomegalovirus-specific T-cell immunity in allogeneic stem cell transplant recipients
Journal of Medical Virology, Vol. 89, Núm. 4, pp. 685-695
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380
2016
2015
-
Cytomegalovirus infection management in allogeneic stem cell transplant recipients: A national survey in Spain
Journal of Clinical Microbiology, Vol. 53, Núm. 8, pp. 2741-2744
-
Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia
Journal of Medical Virology, Vol. 87, Núm. 9, pp. 1601-1607
-
Functional patterns of cytomegalovirus (CMV) pp65 and immediate early-1-specific CD8+ T cells that are associated with protection from and control of CMV DNAemia after allogeneic stem cell transplantation
Transplant Infectious Disease, Vol. 17, Núm. 3, pp. 361-370
-
Incidence and dynamics of active cytomegalovirus infection in allogeneic stem cell transplant patients according to single nucleotide polymorphisms in donor and recipient CCR5, MCP-1, IL-10, and TLR9 genes
Journal of Medical Virology, Vol. 87, Núm. 2, pp. 248-255
-
The genotype of the donor for the (GT)n polymorphism in the promoter/enhancer of FOXP3 Is associated with the development of severe acute GVHD but does not affect the GVL effect after myeloablative HLA-Identical allogeneic stem cell transplantation
PLoS ONE, Vol. 10, Núm. 10